Authors
Loading...
Review reveals that advanced glycation end products drive vascular damage in diabetes, suggesting that inhibiting glycation pathways delays diabetic vasculopathy.
Ahmad et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: